See also this year's filing and all EDGAR filings for this company.
PDF Report 0001865494_2023_IO_Biotech_Inc.pdf
Logs
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss 2': 2, '100060 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 13}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001865494, IO Biotech Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 148,219,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 741,000 |
| 3 | remainder_Assets | 2,845,000 |
| 4 | LiabilitiesCurrent | 10,676,000 |
| 5 | LiabilitiesNoncurrent | 2,275,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,438,000 |
| 9 | ResearchAndDevelopmentExpense | 46,986,000 |
| 10 | remainder_Expenses | 1,273,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,239,000 |
| 13 | remainder_ComprehensiveNetIncome | -8,652,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 151,805,000 |
| 1 | Liabilities | 12,951,000 |
| 2 | Expenses | 72,697,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 138,854,000 |
| 5 | NetIncome | -71,458,000 |
| 6 | ComprehensiveNetIncome | -75,784,000 |
| 7 | BaseVar | 123,672,000 |
| 8 | EconomicCapitalRatio | 1.98 |
Edgar->Model Mapping
Feature Distribution
Change over Time
